Asian Journal of Pharmaceutical Analysis
  • Year: 2023
  • Volume: 13
  • Issue: 2

Analytical Technique for Carvedilol and Ivabradine determination from pure and Pharmaceutical Dosage Forms: A Review

  • Author:
  • Prithviraj B. Chavan*, Mahesh H. Kolhe, Kavita V. Dhamak, Rohit J. Bhor
  • Total Page Count: 7
  • Page Number: 115 to 121

Department of Quality Assurance Technique, Pravara Rural College of Pharmacy, Pravaranagar, Ahmednagar - (MH) India

*Corresponding Author E-mail: pruthvirajchavan69150@gmail.com

Online Published on 03 October, 2023.

Abstract

Carvedilol and ivabradine is a drug combination used to treat cardiovascular diseases like hypertension, chronic stable angina pectoris and, chronic heart failure. Both are different in their mode of action. Carvedilol prevents exercise-induced tachycardia via inhibition of beta-adrenoreceptor carvedilol also acting on alpha-1 adrenergic receptors and an overall reduction in blood pressure. In case of a higher dose also shows antioxidant and calcium channel blocking activity. Ivabradine is a heart rate reducing drug that works by blocking cardiac pacemaker currents (If) selectively and specifically. The major goal of this review paper is to emphasize the characteristics of carvedilol and ivabradine, such as their pharmacological profiles, mechanisms of action, pharmacokinetic and pharmacodynamic studies, and previously described analytical methodologies for carvedilol and ivabradine determination. Various methods such as UV spectroscopy HPLC, RP-HPLC, UPLC. This review deals with the various analytical method reported and adopted for the estimation of carvedilol and ivabradine.

Keywords

Heart failure, Carvedilol, HPLC, Analytical method